A double blind, randomized, placebo-controlled phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS

American Journal of Gastroenterology

Volumn 94, Issue 11, 1999, Pages 3267-3273

  Holodniy, Mark ^a   Koch, Johannes ^b   Mistal, Mark ^a   Schmidt, Jamey Maimares ^b   Khandwala, Atul ^c   Pennington, James E ^c   Porter, Steven B ^c  

^a AIDS Research Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Shaman Botanicalscom   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CROFELEMER; PLACEBO; PROANTHOCYANIDIN DERIVATIVE; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FECES ANALYSIS; FEMALE; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADMINISTRATION, ORAL; ADULT; ANTI-HIV AGENTS; ANTIDIARRHEALS; ANTIVIRAL AGENTS; BIOPOLYMERS; CATECHIN; DIARRHEA; DOUBLE-BLIND METHOD; FECES; FEMALE; FOLLOW-UP STUDIES; HIV PROTEASE INHIBITORS; HUMANS; MALE; MIDDLE AGED; PLACEBOS; SAFETY;

EID: 0032756985     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00594-8     Document Type: Article

References (34)

1. Framm S.R., Soave R. Agents of diarrhea. Med Clin North Am. 81:1997;427-447.
2. Sharpstone D., Gazzard B. Gastrointestinal manifestations of HIV infection. Lancet. 348:1996;379-383.
3. Carr A., Marriot D., Field A., et al. Treatment of HIV-1 associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet. 351:1998;256-261.
4. Foudraine N.A., Weverling G.J., van Gool T., et al. Improvement of chronic diarrhea in patients with advanced HIV-1 infection during potent antiretroviral therapy. AIDS. 12:1998;35-41.
5. Kim L.S., Hadley W.K., Stansell J., et al. Declining prevalence of cryptosporidiosis among patients with AIDS in San Francisco. Clin Infect Dis. 27:1998;655-656.
6. Blanshard C., Gazzard B.G. Natural history and prognosis of diarrhea of unknown cause in patients with acquired immunodeficiency syndrome (AIDS). Gut. 36:1995;283-286.
7. DuPont H.L., Marshall G.D. HIV-associated diarrhea and wasting. Lancet. 346:1995;352-356.
8. McDonald C., Kuritzkes D. Human immunodeficiency virus type 1 protease inhibitors. Arch Intern Med. 157:1997;951-959.
9. Watson A., Samore M.H., Wanke C.A. Diarrhea and quality of life in ambulatory HIV-infected patients. Dig Dis Sci. 41:1996;1794-1800.
10. Lubeck D.P., Bennett C.K., Mazonson P.D., et al. Quality of life and health service use among HIV-infected patients with chronic diarrhea. J Acquired Immune Defic Syndr. 6:1993;478-484.
11. Ubillas R., Jolad S., Bruening R., et al. SP-303, an antiviral oligomeric proanthocyanidin from the latex of Croton lechleri (Sangre de Drago). Phytomed. 1:1994;77-106.
12. McRae W., Hudson J., Towers F. Studies on the pharmacological activity of Amazonian Euphorbiaceas. J Ethnopharmacol. 22:1988;143-172.
13. Von Reis S., Lipp E. New plant sources for drugs and foods from the New York Botanical Garden. 1982;Harvard University Press, Cambridge.
14. Vlietinck A. Biologically active substances from traditional drugs. Hostettmann K., Lea P. Biologically active natural products. 1987;33-47 Claredon Press, Oxford.
15. Persinos-Perdue F., Blomster R., Blake D., et al. South American plants II Taspine isolation and anti-inflammatory activity . J Pharm Sci. 68:1979;124-126.
16. Gabriel S.E., Davenport S.E., Steagall R.J., et al. A novel plant-derived inhibitor of cAMP-mediated fluid and chloride secretion. Am J Physiology. 276:1999;658-663.
17. CDC. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992, 41 (no. RR-17).
18. Gibbons R., Hedeker D., Elkin I., et al. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Arch Gen Psychiatry. 50:1993;739-750.
19. Greenough W.B. Vibrio cholerae and cholera. Mandell G.L., Bennett J.E., Dolin R. Principles and practices of infectious diseases. 4th ed. 1995;1934-1935 Churchill Livingstone, New York.
20. Guerrant R.L. Principles and syndromes of enteric infection. Mandell G.L., Bennett J.E., Dolin R. Principles and practices of infectious diseases. 4th ed. 1995;945-962 Churchill Livingstone, New York.
21. - channel by heat-stable enterotoxin and guanylin via cAMP-dependent protein kinase. EMBO J. 13:1994;1065-1072.
22. Sears C.L., Guerrant R.L., Kaper J.B. Enteric bacterial toxins. Blaser M.J., Smith P.D., Ravdin I., et al. Infections of the gastrointestinal tract. 1995;617-634 Raven Press, New York.
23. Guerrant R.L., Thielman N.M. Types of Escherichia coli and enteropathogens. Blaser M.J., Smith P.D., Ravdin I., et al. Infections of the gastrointestinal tract. 1995;687-707 Raven Press, New York.
24. Donowitz M., Levine S., Watson A. New Drug Treatments for diarrhea. J Intern Med. 228:(suppl 1):1990;155-163.
25. Singh A.K., Afink G.B., Venglarik C.J., et al. Colonic Cl channel blockade by three classes of compounds. Am J Physiol. 260:1991;C51-C63.
26. Rabbani G.H. Mechanism and treatment of diarrhea due to Vibrio cholerae and Escherichia coli Role of drugs and prostaglandins . Dan Med Bull. 43:1996;173-185.
27. Bjarnason I., Sharpstone D.R., Francis N., et al. Intestinal inflammation, ileal structure and function in HIV. AIDS. 10:1996;1385-1391.
28. Lambl B.B., Federman M., Pleskow D., et al. Malabsorption and wasting in AIDS patients with microsporidia and pathogen-negative diarrhea. AIDS. 10:1996;739-744.
29. + secretion in human distal colon driven by prostaglandin E2. Am J Physiol. 271:1996;G669-G674.
30. Sharpstone D.R., Rowbottom A.W., Nelson M.R., et al. Faecal tumor necrosis factor-α in individuals with HIV-related diarrhea. AIDS. 10:1996;989-994.
31. Manfredi R., Vezzadini P., Costigliola P., et al. Elevated plasma levels of vasoactive intestinal peptide in AIDS patients with refractory idiopathic diarrhea. Effects of treatment with octreotide. AIDS. 7:1993;223-226.
32. Simon D.M., Cello J.P., Valenzuela J., et al. Multicenter trial of octreotiede in patients with refractory acquired immunodeficiency syndrome-associated diarrhea. Gastroenterology. 108:1995;1753-1760.
33. Stockman M., Fromm M., Schmitz H., et al. Duodenal biopsies of HIV-infected patients with diarrhea exhibit epithelial barrier defects but no active secretion. AIDS. 12:1998;43-51.
34. Kelly P., Thillainayagam A.V., Smithson J., et al. Jejunal water and electrolyte transport in human cryptosporidiosis. Dig Dis Sci. 41:1996;2095-2099.